Shortcut Navigation:

Breast Cancer News

In this section, access cutting-edge breast cancer news on treatment updates, emerging therapies, study results and other medical and quality-of-life issues important to you.

BRCA variants not tied to worse cancer outcomes

NEW YORK (Reuters Health) - The outlook for breast cancer patients carrying variant versions of the BRCA genes is a subject of debate, but a new study suggests those women do just as well as patients with similar cancers, as long as they follow standard treatments.

Less Heart-Toxic HER2 Chemotherapy Option

If you have been diagnosed with HER2 positive, early-stage breast cancer, find out how you and your healthcare team can reduce the risk of heart-damaging side effects potentially caused by some chemotherapy treatments.

Ovary removal not tied to increased risk of death

NEW YORK (Reuters Health) - Despite concerns that removing both of a woman's ovaries would raise her chances of dying from diseases associated with aging, a large new study suggests the procedure may be safe.

U.S. revokes approval of Avastin for breast cancer

WASHINGTON (Reuters) - U.S. drug regulators on Friday withdrew approval of Roche's Avastin as a treatment for breast cancer, capping a protracted and emotional battle over a drug backed by many survivors of the disease.

Brain scan study finds evidence of 'chemo brain'

CHICAGO (Reuters) - Women who survive breast cancer after undergoing chemotherapy may also have to contend with impairments in attention, memory and planning skills, U.S. researchers said on Monday.

Should you skip alcohol if mom had breast cancer?

NEW YORK (Reuters Health) - A team of U.S. scientists believe they have found a piece of advice that breast cancer -stricken mothers can give their daughters to help them stave off the disease: stay clear of alcohol.

Breast cancer survival gains lag in the elderly

NEW YORK (Reuters Health) - Although fewer and fewer women have died of breast cancer each year over the past two decades, a new study suggests that improvements in survival have been slowest for the oldest women with the disease.

Tamoxifen Reduces ER-positive Recurrence Rate

In a five-year review of 20 clinical trials, tamoxifen was shown to safely reduce both 15-year risk for recurrence and death in early-stage estrogen receptor-positive breast cancer.

Breast cancer risk: It's not all in the family

CHICAGO (Reuters) - Women do not automatically have a higher risk of getting breast cancer just because someone else in the family has tested positive for breast cancer genes, U.S. researchers said Monday.

Doctors split on Avastin for breast cancer: survey

NEW YORK (Reuters Health) - An international survey of cancer doctors shows many question U.S. health advisers' 2010 rejection of Roche's drug Avastin to treat advanced breast cancer.

Denver, CO  ·  September 13, 2014

Join Your Community for Yoga on the Steps!

Close
close